Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
The New Zealand Medical Journal is out tomorrow
The New Zealand Medical Journal is out tomorrow

Editorial
Advocating for the advocates, caring for the caregivers: physician health and wellbeing
Alexandra HR Muthu
Articles
How do intensivists treat their patients, their loved ones and themselves? Results of a survey of intensivists facing an evolving hypothetical clinical scenario
Sachin Gupta, Ravindranath Tiruvoipati, Wei Chun Wang, Cameron Green, John Botha
Incidence of retinopathy of prematurity in Christchurch Hospital, New Zealand over a 10-year period
Louis S Han, Antony Bedggood
Analysis of presenting symptoms and diagnoses made at Middlemore Hospital: an audit carried out between Monday 1 August and Sunday 7 August 2016
Alistair Lock, Matt Wright
Indoor allergen exposure in primary school classrooms in New Zealand
Rob Siebers, Bernadette Jones, Lauren Bailey, Daniel Aldridge, Jessica Draper, Tristram Ingham
Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context
Ben Beaglehole, James Foulds, Roger T Mulder, Joseph M Boden
Reducing days of alcohol use improves lifestyle and wellbeing: an analysis of outcomes data from New Zealand adult community alcohol and other drug services
Jennifer Lai, Paul Hanton, Angela Jury, Charito Tuason
Viewpoint
Developing New Zealand’s medical workforce: realising the potential of longitudinal career tracking
Phillippa Poole, Tim J Wilkinson, Warwick Bagg, Janis Freegard, Fiona Hyland, Emmanuel Jo, Bridget Kool, Eva Roberts, Joy Rudland, Bruce Smith, Antonia Verstappen, for the NZ MSOD Steering Group